Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for… EP News Bureau Jun 7, 2022 Boehringer Ingelheim holds a valid patent for Linagliptin in India until August 2023
US offers USD 30 bn more market to domestic pharma companies Press Trust of India Feb 3, 2020 Despite being the largest export market for domestic pharma makers, they served only a miniscule 5.6 per cent or USD 6.5 billion…
